How to buy Corbus Pharmaceuticals Holding stock (CRBP)

Corbus Pharmaceuticals Holding is a biotechnology business based in the US. Corbus Pharmaceuticals Holding shares (CRBP) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $13.00 – a decrease of 13.79% over the previous week. Corbus Pharmaceuticals Holding employs 19 staff and has a market cap (total outstanding shares value) of 0.00.

Our top picks for where to buy Corbus Pharmaceuticals Holding stock

Buy Corbus Pharmaceuticals Holding stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Corbus Pharmaceuticals Holding stock price (NASDAQ: CRBP)

Use our graph to track the performance of CRBP stocks over time.

Corbus Pharmaceuticals Holding shares at a glance

• Key figures

Information last updated 2024-12-19.

Latest market close	$13.00
52-week range	$5.25 - $61.90
50-day moving average more info button	$17.20
200-day moving average more info button	$37.99
Wall St. target price	$56.78
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-4.71

Is it a good time to buy Corbus Pharmaceuticals Holding stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Corbus Pharmaceuticals Holding price performance over time

Historical closes compared with the close of $13.33 from 2024-12-19

1 week (2024-12-13)	-11.60%
1 month (2024-11-21)	-20.32%
3 months (2024-09-20)	-31.68%
6 months (2024-06-21)	-68.62%

1 year (2023-12-21)	151.04%
2 years (2022-12-21)	303.94%
3 years (2021-12-21)	20.064
5 years (2019-12-20)	155.4

Corbus Pharmaceuticals Holding financials

Gross profit TTM	$-16,136,826
Return on assets TTM	-28.82%
Return on equity TTM	-51.32%
Profit margin	0%
Book value	$12.36
Market Capitalization more info button	$162 million

TTM: trailing 12 months

Corbus Pharmaceuticals Holding share dividends

We're not expecting Corbus Pharmaceuticals Holding to pay a dividend over the next 12 months.

Have Corbus Pharmaceuticals Holding's shares ever split?

Corbus Pharmaceuticals Holding's shares were split on a 1:30 basis on 13 February 2023 . So if you had owned 30 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Corbus Pharmaceuticals Holding shares – just the quantity. However, indirectly, the new 2900% higher share price could have impacted the market appetite for Corbus Pharmaceuticals Holding shares which in turn could have impacted Corbus Pharmaceuticals Holding's share price.

Corbus Pharmaceuticals Holding share price volatility

Over the last 12 months, Corbus Pharmaceuticals Holding's shares have ranged in value from as little as $5.25 up to $61.9. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Corbus Pharmaceuticals Holding's is 2.565. This would suggest that Corbus Pharmaceuticals Holding's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Corbus Pharmaceuticals Holding overview

Corbus Pharmaceuticals Holdings, Inc. , a biopharmaceutical company, develops products to defeat serious illness. It develops CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E (MMAE), which is in Phase I clinical trial; CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells for the treatment of solid tumors; CRB-913, a peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. It has a licensing agreement with Jenrin Discovery, LLC to develop and commercialize the licensed products, including the Jenrin library of approximately 600 compounds, and multiple issued and pending patent filings. The company was incorporated in 2009 and is based in Norwood, Massachusetts. .

Frequently asked questions

null
What percentage of Corbus Pharmaceuticals Holding is owned by insiders or institutions?
Currently 0.75% of Corbus Pharmaceuticals Holding shares are held by insiders and 105.219% by institutions. How many people work for Corbus Pharmaceuticals Holding?
Latest data suggests 19 work at Corbus Pharmaceuticals Holding. When does the fiscal year end for Corbus Pharmaceuticals Holding?
Corbus Pharmaceuticals Holding's fiscal year ends in December. Where is Corbus Pharmaceuticals Holding based?
Corbus Pharmaceuticals Holding's address is: 500 River Ridge Drive, Norwood, MA, United States, 02062 What is Corbus Pharmaceuticals Holding's ISIN number?
Corbus Pharmaceuticals Holding's international securities identification number is: US21833P1030 What is Corbus Pharmaceuticals Holding's CUSIP number?
Corbus Pharmaceuticals Holding's Committee on Uniform Securities Identification Procedures number is: 21833P103